In contrast, the expression level of miR-19a in human cancer specimens was significantly lower than that found in adjacent non-cancerous tissue, which might play an inhibitory role for HCC progression by targeting cyclin D1 [28]. This evidence concerns the gene CCND1 and hepatocellular carcinoma.